{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:20:58Z","timestamp":1791649258091,"version":"4.3.4"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bioorg.2023.107075","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T12:06:31Z","timestamp":1704715591000},"page":"107075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The progress of small molecules against cannabinoid 2 receptor (CB2R)"],"prefix":"10.1016","volume":"144","author":[{"given":"Qinying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.107075_b0005","article-title":"The impact of phyto- and endo-cannabinoids on central nervous system diseases: a review","author":"Zhang","year":"2022","journal-title":"J. Tradit. Complement. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2023.107075_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2019.183051","article-title":"G protein-coupled receptors of class a harness the energy of membrane potential to increase their sensitivity and selectivity","volume":"1861","author":"Shalaeva","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bioorg.2023.107075_b0015","doi-asserted-by":"crossref","unstructured":"F. Shahbazi, V. Grandi, A. Banerjee, J.F. Trant, Cannabinoids and Cannabinoid Receptors: The Story so Far, iScience 23(7) (2020) 101301.","DOI":"10.1016\/j.isci.2020.101301"},{"key":"10.1016\/j.bioorg.2023.107075_b0020","doi-asserted-by":"crossref","unstructured":"T. Hua, X. Li, L. Wu, C. Iliopoulos-Tsoutsouvas, Y. Wang, M. Wu, L. Shen, C.A. Brust, S.P. Nikas, F. Song, X. Song, S. Yuan, Q. Sun, Y. Wu, S. Jiang, T.W. Grim, O. Benchama, E.L. Stahl, N. Zvonok, S. Zhao, L.M. Bohn, A. Makriyannis, Z.J. Liu, Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G(i) Complex Structures, Cell 180(4) (2020) 655-665 e18.","DOI":"10.1016\/j.cell.2020.01.008"},{"key":"10.1016\/j.bioorg.2023.107075_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841766","article-title":"Cannabinoid CB(2) Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease","volume":"13","author":"Ruiz de Martin Esteban","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bioorg.2023.107075_b0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","article-title":"The cannabinoid receptors","volume":"68\u201369","author":"Howlett","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1471-4892(02)00011-5","article-title":"CB1 cannabinoid receptor signalling in Parkinson's disease","volume":"3","author":"Brotchie","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"s1","key":"10.1016\/j.bioorg.2023.107075_b0040","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.3233\/JAD-201045","article-title":"Multi-target effects of the cannabinoid cp55940 on familial alzheimer's disease psen1 e280a cholinergic-like neurons: role of cb1 receptor","volume":"82","author":"Soto-Mercado","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2023.107075_b0045","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.bioorg.2023.107075_b0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"22","key":"10.1016\/j.bioorg.2023.107075_b0060","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1523\/JNEUROSCI.22-22-09771.2002","article-title":"Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice","volume":"22","author":"Sophie Parmentier-Batteur","year":"2002","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2023.107075_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104994","article-title":"Yin and yang of cannabinoid CB1 receptor: CB1 deletion in immune cells causes exacerbation while deletion in non-immune cells attenuates obesity","volume":"25","author":"Miranda","year":"2022","journal-title":"iScience"},{"issue":"18","key":"10.1016\/j.bioorg.2023.107075_b0070","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.bmc.2018.08.003","article-title":"Oximes short-acting CB1 receptor agonists","volume":"26","author":"Malamas","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0075","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/acs.jcim.2c01503","article-title":"Identification of novel CB2 ligands through virtual screening and in vitro evaluation","volume":"63","author":"Stasiulewicz","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.bioorg.2023.107075_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.alcohol.2014.09.023","article-title":"HIV and alcohol in blood brain barrier injury and neuroinflammation: protective effect of cannabinoid type (CB2) receptor agonists","volume":"48","author":"Persidsky","year":"2014","journal-title":"Alcohol"},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2020.12.243","article-title":"Modulation of the endocannabinoid receptor CB2 as a novel treatment for the lysosomal diseases","volume":"132","author":"Simonaro","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/BOR.0000000000000590","article-title":"Joints for joints: cannabinoids in the treatment of rheumatoid arthritis","volume":"31","author":"Lowin","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6441","key":"10.1016\/j.bioorg.2023.107075_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.107075_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphar.2015.00040","article-title":"Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors","volume":"6","author":"de Munnik","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.107075_b0105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/npp.2014.297","article-title":"Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bioorg.2023.107075_b0110","article-title":"Are CB2 Receptors a New Target for Schizophrenia Treatment?","volume":"11","author":"Cortez","year":"2020","journal-title":"Front. Psych."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-021-01196-5","article-title":"Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration","volume":"9","author":"Galan-Ganga","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2023.107075_b0120","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bioorg.2023.107075_b0125","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","article-title":"Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: opposite roles of CB(1) \/CB(2) versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2023.107075_b0130","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1365-2826.2012.02325.x","article-title":"Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice","volume":"24","author":"Romero-Zerbo","year":"2012","journal-title":"J. Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.107075_b0135","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/acs.jcim.5b00739","article-title":"Difference and influence of inactive and active states of cannabinoid receptor subtype CB2: from conformation to drug discovery","volume":"56","author":"Hu","year":"2016","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.bioorg.2023.107075_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076187","article-title":"Allosteric regulation of G-protein-coupled receptors: from diversity of molecular mechanisms to multiple allosteric sites and their ligands","volume":"24","author":"Shpakov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.bioorg.2023.107075_b0145","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB(2) receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.107075_b0155","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ana.23875","article-title":"Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis","volume":"73","author":"Chiurchiu","year":"2013","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/glia.20907","article-title":"Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1\/2, JNK, and NF-kappaB","volume":"58","author":"Correa","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bioorg.2023.107075_b0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroscience.2013.07.040","article-title":"Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice","volume":"250","author":"Ikeda","year":"2013","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.bioorg.2023.107075_b0170","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1021\/jm061195+","article-title":"Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain","volume":"50","author":"Giblin","year":"2007","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2023.107075_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbi.2020.08.024","article-title":"Differential effect of interferon-alpha treatment on AEA and 2-AG levels","volume":"90","author":"Zajkowska","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bioorg.2023.107075_b0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","article-title":"Endocannabinoid System Components as Potential Biomarkers in Psychiatry","volume":"11","author":"Navarrete","year":"2020","journal-title":"Front. Psych."},{"issue":"19","key":"10.1016\/j.bioorg.2023.107075_b0190","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1039\/C4CS00047A","article-title":"Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids","volume":"43","author":"Kohnz","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2023.107075_b0195","doi-asserted-by":"crossref","unstructured":"M. Argenziano, C. Tortora, G. Bellini, A. Di Paola, F. Punzo, F. Rossi, Correction: Argenziano, M., et al. The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases. Int. J. Mol. Sci. 2019, 20, 5875, International Journal of Molecular Sciences 21(8) (2020).","DOI":"10.3390\/ijms21082757"},{"issue":"9","key":"10.1016\/j.bioorg.2023.107075_b0200","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.tips.2022.06.010","article-title":"Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future","volume":"43","author":"Whiting","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"20","key":"10.1016\/j.bioorg.2023.107075_b0205","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1021\/jm200916p","article-title":"Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists","volume":"54","author":"van der Stelt","year":"2011","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ejn.12467","article-title":"Anandamide in primary sensory neurons: too much of a good thing?","volume":"39","author":"Sousa-Valente","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bioorg.2023.107075_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","article-title":"Endocannabinoids and their pharmacological actions","volume":"231","author":"Pertwee","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.107075_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577501","article-title":"Endocannabinoid system: role in blood cell development, neuroimmune interactions and associated disorders","volume":"353","author":"Sharma","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.bioorg.2023.107075_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147711","article-title":"Fatty Acid Amide Hydrolase (FAAH) inhibition modulates amyloid-beta-induced microglia polarization","volume":"22","author":"Grieco","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871529X18666180206161457","article-title":"The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2","volume":"18","author":"Fulmer","year":"2018","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.bioorg.2023.107075_b0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnint.2018.00051","article-title":"Cannabis therapeutics and the future of neurology","volume":"12","author":"Russo","year":"2018","journal-title":"Front. Integr. Neurosci."},{"issue":"16","key":"10.1016\/j.bioorg.2023.107075_b0245","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.bmcl.2016.06.076","article-title":"Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders","volume":"26","author":"Janssen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2020.01.005","article-title":"DAGL-beta functions as a PUFA-specific triacylglycerol lipase in macrophages","volume":"27","author":"Shin","year":"2020","journal-title":"Cell Chem Biol"},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0255","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jcp.29949","article-title":"Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria","volume":"236","author":"Sharma","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioorg.2023.107075_b0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2008.08.027","article-title":"Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells","volume":"1238","author":"Xiao","year":"2008","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0265","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/jpet.105.085282","article-title":"The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors","volume":"314","author":"Shoemaker","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcp.2004.08.033","article-title":"Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor","volume":"69","author":"Steffens","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2023.107075_b0275","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1167\/iovs.05-0729","article-title":"Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility","volume":"47","author":"Njie","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2023.107075_b0280","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/ol063022k","article-title":"Synthesis of (-)-\u03949-trans-Tetrahydrocannabinol: Stereocontrol via Mo-Catalyzed Asymmetric Allylic Alkylation Reaction","volume":"9","author":"Trost","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2023.107075_b0285","unstructured":"P. RG, Pharmacological Actions of Cannabinoids, Cannabinoids. Handbook of experimental pharmacology. 168. Berlin, Heidelberg (2005)."},{"key":"10.1016\/j.bioorg.2023.107075_b0290","first-page":"61","article-title":"Molecular Pharmacology of Phytocannabinoids, Prog Chem Org Nat","volume":"103","author":"Turner","year":"2017","journal-title":"Prod"},{"issue":"4","key":"10.1016\/j.bioorg.2023.107075_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101764","article-title":"Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors","volume":"298","author":"Dutta","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2023.107075_b0300","article-title":"Oral Administration of Cannabis and Delta-9-tetrahydrocannabinol (THC)","volume":"56","author":"Poyatos","year":"2020","journal-title":"Preparations: A Systematic Review, Medicina (kaunas)"},{"key":"10.1016\/j.bioorg.2023.107075_b0305","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.drugalcdep.2018.02.022","article-title":"The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration","volume":"187","author":"Schlienz","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.bioorg.2023.107075_b0310","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2023.107075_b0315","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta(9)-THCV in animal models of Parkinson's disease","volume":"163","author":"Garcia","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.bioorg.2023.107075_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147929","article-title":"The origin and biomedical relevance of cannabigerol","volume":"23","author":"Jastrzab","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.107075_b0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","article-title":"Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures","volume":"46","author":"Rosenthaler","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"issue":"9","key":"10.1016\/j.bioorg.2023.107075_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092774","article-title":"Cannabinoids, phenolics, terpenes and alkaloids of cannabis","volume":"26","author":"Radwan","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2023.107075_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders","volume":"10","author":"Garcia-Gutierrez","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.bioorg.2023.107075_b0340","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2023.107075_b0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2004.01.023","article-title":"6-Azidohex-2-yne-cannabidiol: a potential neutral, competitive cannabinoid CB 1 receptor antagonist","volume":"487","author":"Thomas","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.107075_b0350","unstructured":"U.B.M. Ashwani S. Patil, Yogeeta O. Agrawal, Kalpesh R. Patil,Chandragouda R. Patil, Shreesh Ojha, Charu Sharma, Sameer N. Goyal,, Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: a review."},{"issue":"45","key":"10.1016\/j.bioorg.2023.107075_b0355","doi-asserted-by":"crossref","DOI":"10.1002\/chin.199945328","article-title":"ChemInform Abstract: Pharmacology of Cannabinoid Receptor Ligands","volume":"30","author":"Pertwee","year":"1999","journal-title":"ChemInform"},{"key":"10.1016\/j.bioorg.2023.107075_b0360","doi-asserted-by":"crossref","unstructured":"Z.V. Man-Hee Rhee, Jacob Barg,Michael Bayewitch,Rivka Levy,Lumir Hanus,Aviva Breuer,Raphael Mechoulam, Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase, (1997).","DOI":"10.1021\/jm970126f"},{"key":"10.1016\/j.bioorg.2023.107075_b0365","doi-asserted-by":"crossref","unstructured":"L. Vollner, D. Bieniek, F. Korte, Cannabidivarin, a new Haschisch-Inhaltsstoff, (1969) 145-147.","DOI":"10.1016\/S0040-4039(01)87494-3"},{"key":"10.1016\/j.bioorg.2023.107075_b0370","unstructured":"A.S.-R. Megan N. Huizenga, Patrick A. Forcelli, Preclinical safety and efficacy of cannabidivarin for early life seizures."},{"key":"10.1016\/j.bioorg.2023.107075_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104822","article-title":"Cannabis sativa: Much more beyond \u03949-tetrahydrocannabinol","volume":"157","author":"Alves","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2023.107075_b0380","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejmech.2019.07.036","article-title":"Strategies to develop selective CB(2) receptor agonists from indole carboxamide synthetic cannabinoids","volume":"180","author":"Moir","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103545","article-title":"1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists","volume":"15","author":"Tarawneh","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0390","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2018.12.008","article-title":"Benzo[d]thiazol-2(3H)-ones as new potent selective CB(2) agonists with anti-inflammatory properties","volume":"165","author":"Leleu-Chavain","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejmech.2019.07.002","article-title":"Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties","volume":"180","author":"Ghonim","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2023.107075_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127507","article-title":"Synthesis of flutamide-conjugates","volume":"30","author":"Medina-Rojas","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.bioorg.2023.107075_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127501","article-title":"7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands","volume":"30","author":"Penthala","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2023.107075_b0410","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1039\/C8MD00448J","article-title":"Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold","volume":"9","author":"Cooper","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2023.107075_b0415","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejmech.2018.09.070","article-title":"Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease","volume":"161","author":"Mugnaini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0420","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-023-03035-9","article-title":"The pyridazine heterocycle in molecular recognition and drug discovery","author":"Meanwell","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0425","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bmcl.2008.10.118","article-title":"Pyridine-3-carboxamides as novel CB(2) agonists for analgesia","volume":"19","author":"Mitchell","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2023.107075_b0430","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1039\/C8MD00461G","article-title":"Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction","volume":"9","author":"Tonelli","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2023.107075_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116035","article-title":"Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189","volume":"33","author":"Alghamdi","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exer.2019.03.013","article-title":"Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189","volume":"182","author":"Guley","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"68","key":"10.1016\/j.bioorg.2023.107075_b0445","doi-asserted-by":"crossref","first-page":"15839","DOI":"10.1002\/chem.202003389","article-title":"Discovery of homobivalent bitopic ligands of the cannabinoid cb(2) receptor*","volume":"26","author":"Morales","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2023.107075_b0450","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejmech.2017.05.060","article-title":"Developing pyridazine-3-carboxamides to be CB2 agonists: the design, synthesis, structure-activity relationships and docking studies","volume":"137","author":"Qian","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127849","article-title":"Pyridones in drug discovery: recent advances","volume":"38","author":"Zhang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2023.107075_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011212","article-title":"New pyridone-based derivatives as cannabinoid receptor type 2 agonists","volume":"22","author":"Faundez-Parraguez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0465","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10561-021-09917-9","article-title":"Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study","volume":"23","author":"Onay","year":"2022","journal-title":"Cell Tissue Bank."},{"issue":"9","key":"10.1016\/j.bioorg.2023.107075_b0470","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/ejoc.200400738","article-title":"Pyrimidine-Annulated Pyrrolobenzodiazepines. A new ring system related to aspergillus alkaloids","volume":"2005","author":"Schmidt","year":"2005","journal-title":"Eur. J. Org. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0475","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020509","article-title":"Identification of an orally bioavailable, brain-penetrant compound with selectivity for the cannabinoid type 2 receptor","volume":"27","author":"Ospanov","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.107075_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119422","article-title":"Mid-infrared spectroscopy as process analytical technology tool for estimation of THC and CBD content in Cannabis flowers and extracts","volume":"251","author":"Geskovski","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"4","key":"10.1016\/j.bioorg.2023.107075_b0485","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041382","article-title":"Fenchone derivatives as a novel class of CB2 selective ligands: design, synthesis, X-ray structure and therapeutic potential","volume":"27","author":"Smoum","year":"2022","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.bioorg.2023.107075_b0490","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1016\/j.bmc.2013.09.040","article-title":"Development of fluorinated CB(2) receptor agonists for PET studies","volume":"21","author":"Lueg","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0495","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2015.01.028","article-title":"Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor","volume":"92","author":"Slavik","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2023.107075_b0500","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/jnc.13716","article-title":"Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2","volume":"138","author":"Slavik","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2023.107075_b0505","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejmech.2017.12.097","article-title":"Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6\/2 chorea huntington mouse model and human ALS spinal cord tissue","volume":"145","author":"Haider","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2023.107075_b0510","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1021\/jm8002203","article-title":"Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain","volume":"51","author":"Diaz","year":"2008","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0515","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13062-019-0241-1","article-title":"MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway","volume":"14","author":"Rao","year":"2019","journal-title":"Biol. Direct"},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0520","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bmcl.2014.11.040","article-title":"Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists","volume":"25","author":"Han","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0525","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/acs.jmedchem.0c01023","article-title":"From a designer drug to the discovery of selective cannabinoid type 2 receptor agonists with favorable pharmacokinetic profiles for the treatment of systemic sclerosis","volume":"64","author":"Jiang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2023.107075_b0530","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1021\/acs.jmedchem.5b00227","article-title":"Development of quinoline-2,4(1H,3H)-diones as potent and selective ligands of the cannabinoid type 2 receptor","volume":"58","author":"Han","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0535","doi-asserted-by":"crossref","unstructured":"I.V. Ukrainets, L. Yangyang, N.L. Bereznyakova, A.V. Turov, 4-hydroxy-2-quinolones. 169*. Synthesis and bromination of 1-allyl-3-(arylamino-methylene)quinoline-2,4-(1h,3h)-diones, Chem. Heterocyclic Compounds 45(10) (2009) 1235-1240.","DOI":"10.1007\/s10593-010-0412-6"},{"issue":"6","key":"10.1016\/j.bioorg.2023.107075_b0540","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1021\/acsmedchemlett.7b00007","article-title":"Development of quinazoline\/pyrimidine-2,4(1H,3H)-diones as agonists of cannabinoid receptor type 2","volume":"8","author":"Qian","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2023.107075_b0545","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1039\/C9MD00173E","article-title":"Indole compounds with N-ethyl morpholine moieties as CB2 receptor agonists for anti-inflammatory management of pain: synthesis and biological evaluation","volume":"10","author":"Li","year":"2019","journal-title":"MedChemComm"},{"issue":"5","key":"10.1016\/j.bioorg.2023.107075_b0550","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bmcl.2008.01.042","article-title":"Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity","volume":"18","author":"Ermann","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.bioorg.2023.107075_b0555","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.bmcl.2007.09.004","article-title":"N-Alkylidenearylcarboxamides as new potent and selective CB(2) cannabinoid receptor agonists with good oral bioavailability","volume":"17","author":"Ohta","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0560","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.forsciint.2012.08.047","article-title":"URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products","volume":"227","author":"Uchiyama","year":"2013","journal-title":"Forensic Sci. Int."},{"issue":"16","key":"10.1016\/j.bioorg.2023.107075_b0565","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1021\/acs.jmedchem.7b00724","article-title":"Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis","volume":"60","author":"Shi","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2023.107075_b0570","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acsmedchemlett.7b00396","article-title":"Discovery of APD371: identification of a highly potent and selective CB2 agonist for the treatment of chronic pain","volume":"8","author":"Han","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.107075_b0575","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmech.2015.01.054","article-title":"Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor","volume":"93","author":"Han","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0580","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","article-title":"SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi-Carmona","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"21","key":"10.1016\/j.bioorg.2023.107075_b0585","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1021\/jm500807e","article-title":"CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-naphthyridin-2(1H)-one-3-carboxamides","volume":"57","author":"Lucchesi","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.107075_b0590","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4155\/fmc.11.179","article-title":"Latest advances in novel cannabinoid CB2 ligands for drug abuse and their therapeutic potential","volume":"4","author":"Yang","year":"2012","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.107075_b0595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejps.2012.10.020","article-title":"Discovery of novel cannabinoid receptor ligands by a virtual screening approach: Further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists","volume":"48","author":"Yrj\u00f6l\u00e4","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.bioorg.2023.107075_b0600","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1016\/j.bmc.2016.08.055","article-title":"Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists\/inverse agonists","volume":"24","author":"Dore","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2023.107075_b0605","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1016\/j.bmc.2010.05.058","article-title":"Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)","volume":"18","author":"Horti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2023.107075_b0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41401-018-0035-5","article-title":"Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system","volume":"40","author":"Ni","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bioorg.2023.107075_b0615","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11307-021-01655-4","article-title":"In vivo imaging of cannabinoid type 2 receptors: functional and structural alterations in mouse model of cerebral ischemia by PET and MRI","volume":"24","author":"Ni","year":"2021","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.bioorg.2023.107075_b0620","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2016.07.012","article-title":"Discovery of novel tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: the structural elements controlling binding affinity, selectivity and functionality","volume":"122","author":"Osman","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107075_b0625","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejps.2014.11.003","article-title":"Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists","volume":"67","author":"Yrj\u00f6l\u00e4","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.bioorg.2023.107075_b0630","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/acschemneuro.3c00580","article-title":"Discovery of potent and selective CB2 agonists utilizing a function-based computational screening protocol","volume":"14","author":"Ge","year":"2023","journal-title":"ACS Chem. Nerosci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823007368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823007368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:33Z","timestamp":1758617193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823007368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":126,"alternative-id":["S0045206823007368"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.107075","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The progress of small molecules against cannabinoid 2 receptor (CB2R)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.107075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107075"}}